• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾癌的新辅助治疗]

[Neoadjuvant therapy for renal cancer].

作者信息

Thibault F, Rixe O, Meric J-B, Renard-Penna R, Boostan H, Mozer P, Comperat E, Richard F, Bitker M-O

机构信息

Service d'urologie, d'oncologie médicale de radiologie et de pathologie, hôpital de la Pitié-Salpêtrière, université Pierre-et-Marie-Curie, 47, boulevard de l'Hôpital, 75013 Paris, France.

出版信息

Prog Urol. 2008 Apr;18(4):256-8. doi: 10.1016/j.purol.2008.01.002. Epub 2008 May 2.

DOI:10.1016/j.purol.2008.01.002
PMID:18501308
Abstract

A 73-year-old man presented with renal cell carcinoma of the left kidney. Despite the absence of metastases, primary nephrectomy was not performed immediately due to the large tumour volume and the presence of large lymph node extension. The patient was treated with sunitinib for 10 months. Computed tomography at the end of treatment showed a significant reduction of the size of the tumour and the volume of lymph node extension. Radical nephrectomy was then performed. On histological evaluation, the primary renal tumour and, to a lesser degree, the lymph nodes were predominantly necrotic.

摘要

一名73岁男性因左肾肾细胞癌就诊。尽管没有转移,但由于肿瘤体积大且存在广泛的淋巴结转移,未立即进行根治性肾切除术。该患者接受了10个月的舒尼替尼治疗。治疗结束时的计算机断层扫描显示肿瘤大小和淋巴结转移体积显著减小。随后进行了根治性肾切除术。组织学评估显示,原发性肾肿瘤以及程度较轻的淋巴结主要为坏死。

相似文献

1
[Neoadjuvant therapy for renal cancer].[肾癌的新辅助治疗]
Prog Urol. 2008 Apr;18(4):256-8. doi: 10.1016/j.purol.2008.01.002. Epub 2008 May 2.
2
Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.新辅助舒尼替尼治疗不可切除的原发性肾细胞癌的计算机断层扫描特征。
Clin Genitourin Cancer. 2014 Apr;12(2):117-23. doi: 10.1016/j.clgc.2013.08.001. Epub 2013 Oct 12.
3
Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.新辅助舒尼替尼治疗后肿瘤负荷显著降低,随后行双侧肾部分切除术。
Urology. 2012 Feb;79(2):e11. doi: 10.1016/j.urology.2011.04.018. Epub 2011 Jun 15.
4
[NEOADJUVANT TARGET THERAPY IN A RENAL-CELL CANCER].[肾细胞癌的新辅助靶向治疗]
Klin Khir. 2015 Dec(12):41-3.
5
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.两名原发性肾细胞癌患者在接受舒尼替尼预处理时出现腔静脉血栓进展。
Acta Oncol. 2010 May;49(4):520-3. doi: 10.3109/02841860903521111.
6
The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery.舒尼替尼对原发性肾细胞癌的疗效及对后续手术的促进作用。
J Urol. 2012 May;187(5):1548-54. doi: 10.1016/j.juro.2011.12.075. Epub 2012 Mar 14.
7
Sunitinib for treatment of advanced renal cell cancer: primary tumor response.舒尼替尼治疗晚期肾细胞癌:原发肿瘤反应
Clin Cancer Res. 2008 Apr 15;14(8):2431-6. doi: 10.1158/1078-0432.CCR-07-4089.
8
Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma.术前使用舒尼替尼可缩小肿瘤大小,并可能有助于肾细胞癌患者进行部分肾切除术。
Urol Oncol. 2015 Mar;33(3):112.e15-21. doi: 10.1016/j.urolonc.2014.11.009. Epub 2014 Dec 19.
9
Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.针对转移性肾细胞癌,在使用舒尼替尼进行靶向治疗后施行减瘤性肾切除术:外科视角
Urol Int. 2012;89(1):83-8. doi: 10.1159/000338057. Epub 2012 May 16.
10
Successful treatment of T4 renal cell carcinoma after a neoadjuvant targeted therapy using sunitinib: report of a case.舒尼替尼新辅助靶向治疗后T4期肾细胞癌的成功治疗:病例报告
Kurume Med J. 2011;58(3):95-8. doi: 10.2739/kurumemedj.58.95.

引用本文的文献

1
Integrating metastasectomy and stereotactic radiosurgery in the treatment of metastatic renal cell carcinoma.在转移性肾细胞癌治疗中整合转移灶切除术和立体定向放射治疗
EJC Suppl. 2013 Sep;11(2):192-203. doi: 10.1016/j.ejcsup.2013.07.017.